Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025

Rhea-AI Summary

Vanda Pharmaceuticals (NASDAQ: VNDA) has scheduled its first quarter 2025 financial results announcement for Wednesday, May 7, 2025, after market close. The company will host a conference call at 4:30 PM ET the same day to discuss quarterly results and corporate activities. Investors can join via phone using the numbers 1-800-715-9871 (domestic) or 1-646-307-1963 (international) with passcode 9941754.

The call will be simultaneously broadcast and archived on www.vandapharma.com. A replay will be available from 8:30 PM ET on May 7 until 11:59 PM ET on May 14, 2025, accessible at 1-800-770-2030 (domestic) or 1-609-800-9909 (international) using the same passcode.

News Market Reaction

+2.93%

1 alert

+2.93% News Effect

On the day this news was published, VNDA gained 2.93%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference Call and Webcast to Follow

WASHINGTON, May 2, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2025 on Wednesday, May 7, 2025, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, May 7, 2025, during which management will discuss the first quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 9941754.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, May 7, 2025, beginning at 8:30 PM ET and will be accessible until Wednesday, May 14, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 9941754.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2025-financial-results-on-may-7-2025-302445033.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals (VNDA) report Q1 2025 earnings?

Vanda Pharmaceuticals will report Q1 2025 earnings on Wednesday, May 7, 2025, after the market closes.

What time is Vanda Pharmaceuticals' (VNDA) Q1 2025 earnings call?

Vanda's Q1 2025 earnings conference call is scheduled for 4:30 PM ET on Wednesday, May 7, 2025.

How can I access Vanda Pharmaceuticals' Q1 2025 earnings call?

You can access the call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) using passcode 9941754, or via webcast on www.vandapharma.com.

How long will Vanda Pharmaceuticals' Q1 2025 earnings call replay be available?

The earnings call replay will be available from 8:30 PM ET on May 7 until 11:59 PM ET on May 14, 2025.